BIOINFORM SUBSCRIBERS: TimeLogic Restructures Staff, Pursues Series A Funding in Response to Disappointing Q4 Sales

Jan 16, 2002

This article is available to subscribers of BioInform.

Breaking News

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.